H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 1.58 CNY Market Closed
Market Cap: ¥7.7B

Relative Value

The Relative Value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 1.58 CNY, Hubei Biocause Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hubei Biocause Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Hubei Biocause Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
CN
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
7.8B CNY 0.2 -10.1 0.4
ZA
Sanlam Ltd
JSE:SLM
223.1B ZAR 1.7 10 2.2
CN
China Life Insurance Co Ltd
SSE:601628
1.3T CNY 3.3 7.4 2
ZA
Discovery Ltd
JSE:DSY
174.8B ZAR 2 18.7 2.7
CN
Ping An Insurance Group Co of China Ltd
SSE:601318
1.1T CNY 1.3 8.2 1.2
HK
AIA Group Ltd
HKEX:1299
913B HKD 4.5 19.3 2.9
ZA
OUTsurance Group Ltd
JSE:OUT
112.1B ZAR 2.9 23.8 7.7
ZA
Old Mutual Ltd
JSE:OMU
71.8B ZAR 0.5 11 1.2
CA
Manulife Financial Corp
TSX:MFC
80.9B CAD 2.1 15.3 1.6
IN
Life Insurance Corporation Of India
NSE:LICI
5.4T INR 0.6 10.2 3.8
US
Aflac Inc
NYSE:AFL
59B USD 3.4 16.2 2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett